Bioxytran Announces Broad Spectrum Antiviral Activity
BOSTON, MASSACHUSETTS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral...
United States Michael Sheikh Bioxytran Inc Human Respiratory Syncytial Virus Respiratory Syncytial Virus Upper Respiratory Infections
Source: globenewswire.com